Observational data on the antiagitation effect of risperidone tablets in emergency settings: A preliminary report

International Journal of Psychiatry in Clinical Practice

Volumn 7, Issue 3, 2003, Pages 217-221

  Yildiz, Aysegul ^a,b,d   Turgay, Atilla ^c   Alpay, Menekse ^b   Sachs, Gary S ^b  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d NONE   (Turkey)

Author keywords

Acute agitation; Atypical antipsychotics; Oral formulations

Indexed keywords

HALOPERIDOL; LORAZEPAM; RISPERIDONE;

ADULT; AGGRESSION; AGITATION; AKATHISIA; ANORGASMIA; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRY NOSE; DYSTONIA; EMERGENCY TREATMENT; FEMALE; HEART ARRHYTHMIA; HUMAN; IMPOTENCE; JAUNDICE; LIBIDO DISORDER; MALE; MYDRIASIS; NAUSEA; NEUROLEPTIC MALIGNANT SYNDROME; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RATING SCALE; SEDATION; SEIZURE; SIDE EFFECT; TABLET; TREATMENT OUTCOME; URINE RETENTION; VISUAL IMPAIRMENT; VOMITING; XEROSTOMIA;

EID: 0141782376     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.1080/13651500310000889     Document Type: Article

References (16)

1. Allen MH (2000) Managing the agitated psychotic patient: a reappraisal of the evidence. J Clin Psychiatry 61 (Suppl 14): 11-20.
2. Brook S, Lucey JV, Gunn KP (2000) Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. J Clin Psychiatry 61: 933-41.
3. Wright P, Birkett M, David SR et al (2001) Double-blind, placebo controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry 158: 1149-51.
4. Jones B, Taylor CC, Meehan K (2001) The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms. J Clin Psychiatry 62 (Suppl 2): 22-4.
5. Meehan K, Zhang F, David S et al (2001) A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo, in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol 21: 389-97.
6. Daniel DG, Potkin SG, Reeves KR et al (2001) Intramuscular ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double blind, randomized trial. Psychopharmacology 155: 128-34.
7. Currier GW, Simpson GM (2001) Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. J Clin Psychiatry 62: 153-7.
8. Foster S, Kessel J, Berman ME, Simpson GM (1997) Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting. Int Clin Psychopharmacol 12: 175-9.
9. Lindenmayer JP (2000) Pathophysiology of agitation. J Clin Psychiatry 61 (Suppl 14): 5-10.
10. Yildiz A, Sachs GS, Turgay A. Pharmacological management of agitation in emergency settings. Emerg Med J (in press).
11. Tesar GE (1993) The agitated patient. Part I: Evaluation and behavioral management. Hosp Community Psychiatry 44: 329-31.
12. Fitzgerald P (1999) Long acting antipsychotic medication, restraint and treatment in the management of acute psychosis. Aust NZ J Psychiatry 33: 660-6.
13. Dubin WR, Feld JA (1989) Rapid tranquilization of the violent patient. Am J Emerg Med 7: 313-20.
14. Dubin WR, Workman HM, Weiss KJ et al (1985) Rapid tranquilization: the efficacy of oral concentrate. J Clin Psychiatry 46: 475-8.
15. Coffman JA, Nasrallah HA, Lyskowski J et al (1987) Clinical effectiveness of oral and parenteral rapid neuroleptization. J Clin Psychiatry 48: 20-4.
16. Daniel DG, Potkin SG, Reeves KR et al (2001) Intramuscular ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double blind, randomized trial. Psychopharmacology 155: 128-34.